Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ANIX | CLUSTER | bullish | 4/10 | Two Anixa insiders, including the CEO and a director, made open-market purchases totaling $151K in late September 2026. | Sep 28, 2026 |
| CYTK | CLUSTER | bearish | 5/10 | Two CYTK insiders, including the CEO and EVP of R&D, sold a combined $730K in open-market sales over a one-week window. | Sep 27, 2026 |
| CYPH | CLUSTER | bearish | 4/10 | Two directors of CYPHERPUNK TECHNOLOGIES INC. sold a combined $855K in open-market sales over a one-week window, represe | Sep 25, 2026 |
| UTHR | CLUSTER | neutral | 4/10 | CEO Martine Rothblatt and EVP Paul Mahon sold a combined $2.45M in open-market shares over a one-week window. Rothblatt' | Sep 25, 2026 |
| TWST | CLUSTER | neutral | 3/10 | Three TWST insiders, including CEO Emily Leproust, sold a total of ~$273K in open-market sales over a 7-day window. The | Sep 25, 2026 |
| PHVS | CLUSTER | bearish | 6/10 | A significant insider selling cluster at Pharvaris N.V. (PHVS) totaling $7.46M in open-market sales over a one-week peri | Sep 25, 2026 |
| MLYS | CLUSTER | bearish | 5/10 | Three insiders at Mineralys Therapeutics sold a total of $3.30M in stock over a one-week window, led by director Brian T | Sep 24, 2026 |
| RVMD | CLUSTER | bearish | 4/10 | Eight Revolution Medicines insiders sold a total of $6.07M in open-market sales over a one-week window, including the CO | Sep 24, 2026 |
| CRSP | CLUSTER | bearish | 5/10 | Two CRISPR Therapeutics insiders—Director Ali Behbahani and General Counsel James Kasinger—sold a combined $1.41M in ope | Sep 24, 2026 |
| SKYE | CLUSTER | neutral | 3/10 | Two insiders at Skye Bioscience sold a combined $108K in open-market sales over a one-week window. The sales are modest | Sep 24, 2026 |
| UTHR | CLUSTER | bearish | 4/10 | CEO Martine Rothblatt sold ~$10.7M in open-market shares over Sept 18-22, 2026, alongside option exercises. EVP Paul Mah | Sep 24, 2026 |
| PHVS | CLUSTER | bearish | 5/10 | Eight insiders at Pharvaris sold a total of ~$7.35M in open-market sales over a 7-day window, including the President ($ | Sep 24, 2026 |
| PHVS | CLUSTER | bearish | 7/10 | Eight Pharvaris insiders sold a total of $7.35M in open-market sales over a one-week window, including the President ($3 | Sep 24, 2026 |
| AMPH | CLUSTER | neutral | 3/10 | Two Amphastar insiders, including the CFO and a senior EVP, sold a combined $343K in open-market sales over a one-week w | Sep 23, 2026 |
| ETRA | CLUSTER | bullish | 6/10 | OrbiMed Advisors LLC and Carl L. Gordon, both directors and 10% owners of Electra Therapeutics, made open-market purchas | Sep 23, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP Paul Mahon executed a cluster of open-market sales totaling ~$14.8M over Sept 17-21, 2026. | Sep 23, 2026 |
| PHVS | CLUSTER | bearish | 6/10 | A massive insider selling cluster at Pharvaris: 9 insiders sold ~$14.4M in open-market sales within a week, including th | Sep 23, 2026 |
| TWST | CLUSTER | bearish | 5/10 | CEO Emily Leproust executed a massive derivative exercise and open-market sale of ~$55M in TWST stock on September 17, 2 | Sep 22, 2026 |
| CSTL | CLUSTER | bearish | 4/10 | CEO Derek Maetzold and CCO Tobin Juvenal sold a combined $419K in open-market sales over a one-week window. The total re | Sep 22, 2026 |
| MLYS | CLUSTER | neutral | 3/10 | Two insiders at Mineralys Therapeutics sold a combined $295K in open-market transactions over a week. The sales are mode | Sep 22, 2026 |
| FDMT | CLUSTER | bearish | 4/10 | Two insiders at 4D Molecular Therapeutics sold a total of $833K in shares over a week, led by CEO David Kirn with $811K | Sep 22, 2026 |
| CYTK | CLUSTER | bearish | 5/10 | CEO Robert Blum sold $6.79M worth of CYTK shares in an open-market transaction, representing the vast majority of a $7.1 | Sep 22, 2026 |
| RVMD | CLUSTER | bearish | 4/10 | Seven insiders at Revolution Medicines, including the CFO, COO, and General Counsel, collectively sold approximately $7. | Sep 22, 2026 |
| TEVA | CLUSTER | bearish | 4/10 | Two Teva insiders sold a combined $14.53M in shares on September 18, 2026. Director Roberto Mignone accounted for the va | Sep 22, 2026 |
| UTHR | CLUSTER | neutral | 4/10 | Chairperson & CEO Martine Rothblatt and EVP & General Counsel Paul Mahon sold a combined ~$12.1M in open-market sales of | Sep 21, 2026 |
| ELVN | CLUSTER | neutral | 2/10 | Two senior executives at Enliven Therapeutics (CMO and CFO) conducted open-market sales totaling ~$323K within a 7-day w | Sep 21, 2026 |
| ORKA | CLUSTER | bearish | 5/10 | Five Oruka Therapeutics insiders, including the CEO, COO, General Counsel, Chief Medical Officer, and SVP of Finance, ex | Sep 21, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | A cluster of insider sales at United Therapeutics follows the company's $477.6M accelerated share repurchase agreement. | Sep 21, 2026 |
| PHVS | CLUSTER | bearish | 5/10 | A cluster of insider selling at Pharvaris N.V. (PHVS) has emerged over the past week, with 7 insiders including the CEO, | Sep 21, 2026 |
| NTHI | CLUSTER | mixed | 5/10 | Three insiders at NeOnc Technologies traded within a week of a dilutive $15M offering. CEO Amir Heshmatpour made two ope | Sep 18, 2026 |